I love me some freshly made, soft bashing IDs! I wonder why someone would go through the hassle to make multiple IDs to try and scare retail investors on a YMB?
if the data are low 80s again (which I expect while others are screaming for 90s) then the resident troll will have a field day
How many more variables will need to be added to get to a test is valuable for the RUO community if it is 80/80?
Great post august. Thank you for your hard work.
good luck longs. a RUO with a Univariate sens/spec of 80%? If august is to be beleived, each additional variable is going to cost the researcher more $$$. how many are needed to get a decent result that the RUO community can use? no one knows. Now you know why they needed the extra 1,000,000,000 shares. Lympro isnt going to make enough money to push MANF forward.
good luck everyone, if you are here for MANF you are here for the looong haul.
it is a bit much. do people really think that yahoo message boards swing the stock price? they are here for retail to chat and do due diligence.
nice post biotech
as a molecular biologist, I can tell you that RNAi is a powerful tool in the lab. Now, if the delivery system is proven to be effective, it can be a powerful tool in the clinic
criticism of questions is much different than personal attacks wouldnt you say scappy?
people are too emotionally involved in this issue
i agree it is an exception
most biotechs in my experience get shorted heavy on pending news, they often dont have positive results. its a decent bet to bet against them
the recent discussion from RBC helps me believe the news will be good, and the short numbers are from end of august remember?
back to personal attacks i see. it really is sad that you do that MKF. im sorry that I havent followed you in QCOR, Im kind of busy.
the problem for you is that Synacthen is synthetic and NOT found in nature. it is the first 24 AA of ACTH. quite a quandary - i see why you dodged the question, its a hard one - just like my question about patent expiration for MANF.
I said I make diagnostics, not drugs, may want to keep your story straight.
good links MKF
Any idea what "New Chemical Entity" means in the CFR?
If a drug product that contains a new chemical entity was approved after September 24, 1984, in an application submitted under section 505(b) of the act, no person may submit a 505(b)(2) application or abbreviated new drug application under section 505(j) of the act for a drug product that contains the same active moiety as in the new chemical entity for a period of 5 years from the date of approval of the first approved new drug application, except that the 505(b)(2) application or abbreviated application may be submitted after 4 years if it contains a certification of patent invalidity or noninfringement described in § 314.50(i)(1)(i)(A)(4) or § 314.94(a)(12)(i)(A)(4).
Does MANF qualify as a New Chemical Entity? It was discovered a LOOONG time ago, and is found in nature....